Synmosa Biopharma Corporation (4114.TWO)

TWD 33.45

(0.0%)

Net Income Summary of Synmosa Biopharma Corporation

  • Synmosa Biopharma Corporation's latest annual net income in 2023 was 594.83 Million TWD , down -25.56% from previous year.
  • Synmosa Biopharma Corporation's latest quarterly net income in 2024 Q2 was 202.36 Million TWD , up 11.45% from previous quarter.
  • Synmosa Biopharma Corporation reported an annual net income of 799.09 Million TWD in 2022, up 162.98% from previous year.
  • Synmosa Biopharma Corporation reported an annual net income of 303.86 Million TWD in 2021, down -52.38% from previous year.
  • Synmosa Biopharma Corporation reported a quarterly net income of 181.58 Million TWD for 2024 Q1, up 6.38% from previous quarter.
  • Synmosa Biopharma Corporation reported a quarterly net income of 170.69 Million TWD for 2023 Q4, up 26.97% from previous quarter.

Annual Net Income Chart of Synmosa Biopharma Corporation (2023 - 2019)

Historical Annual Net Income of Synmosa Biopharma Corporation (2023 - 2019)

Year Net Income Net Income Growth
2023 594.83 Million TWD -25.56%
2022 799.09 Million TWD 162.98%
2021 303.86 Million TWD -52.38%
2020 638.11 Million TWD 1255.09%
2019 47.09 Million TWD 0.0%

Peer Net Income Comparison of Synmosa Biopharma Corporation

Name Net Income Net Income Difference
Allied Biotech Corporation 97.41 Million TWD -510.635%
GeneFerm Biotechnology Co., Ltd. 124.62 Million TWD -377.313%
Easywell Biomedicals, Inc. -144.81 Million TWD 510.745%
TTY Biopharm Company Limited 1.12 Billion TWD 47.29%
Orient EuroPharma Co., Ltd. 143.94 Million TWD -313.241%
Center Laboratories, Inc. -995.42 Million TWD 159.757%
Tien Liang BioTech Co., Ltd. 17.73 Million TWD -3254.568%
Orient Pharma Co., Ltd. 22.28 Million TWD -2568.844%
InnoPharmax Inc. -70.83 Million TWD 939.79%
Johnson Chemical Pharmaceutical Works Co., Ltd. 79.7 Million TWD -646.339%
Excelsior Biopharma Inc. -91.01 Million TWD 753.583%
DV Biomed Co., Ltd. 162.91 Million TWD -265.129%
Foresee Pharmaceuticals Co., Ltd. -1.03 Billion TWD 157.399%
Handa Pharmaceuticals, Inc. 726.88 Million TWD 18.167%
UniPharma Co., Ltd. -21.81 Million TWD 2826.961%
Anxo Pharmaceutical Co., Ltd. 21.86 Million TWD -2620.973%
Alar Pharmaceuticals Inc. 382.61 Million TWD -55.464%
Winston Medical Supply Co., Ltd. 158.75 Million TWD -274.686%
Mercury Biopharmaceutical Corporation -43.81 Million TWD 1457.568%
Bioray Biotech Co., Ltd -11.55 Million TWD 5246.051%
TSH Biopharm Corporation Limited 61.98 Million TWD -859.577%